153 related articles for article (PubMed ID: 34209278)
21. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
Huang L; Ao Q; Zhang Q; Yang X; Xing H; Li F; Chen G; Zhou J; Wang S; Xu G; Meng L; Lu Y; Ma D
J Cancer Res Clin Oncol; 2010 Mar; 136(3):447-56. PubMed ID: 19760195
[TBL] [Abstract][Full Text] [Related]
22. NADPH oxidase NOX4 is a glycolytic regulator through mROS-HIF1α axis in thyroid carcinomas.
Tang P; Dang H; Huang J; Xu T; Yuan P; Hu J; Sheng JF
Sci Rep; 2018 Oct; 8(1):15897. PubMed ID: 30367082
[TBL] [Abstract][Full Text] [Related]
23. NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling.
Ryu D; Lee JH; Kwak MK
Arch Pharm Res; 2020 Dec; 43(12):1297-1310. PubMed ID: 33242180
[TBL] [Abstract][Full Text] [Related]
24. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27
Antony S; Jiang G; Wu Y; Meitzler JL; Makhlouf HR; Haines DC; Butcher D; Hoon DS; Ji J; Zhang Y; Juhasz A; Lu J; Liu H; Dahan I; Konate M; Roy KK; Doroshow JH
Mol Carcinog; 2017 Dec; 56(12):2643-2662. PubMed ID: 28762556
[TBL] [Abstract][Full Text] [Related]
25. Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
Shen CJ; Chang KY; Lin BW; Lin WT; Su CM; Tsai JP; Liao YH; Hung LY; Chang WC; Chen BK
Theranostics; 2020; 10(16):7083-7099. PubMed ID: 32641980
[No Abstract] [Full Text] [Related]
26. NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.
Khalil HS; Langdon SP; Kankia IH; Bown J; Deeni YY
Oxid Med Cell Longev; 2016; 2016():4148791. PubMed ID: 26770651
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.
Wang Y; Ma J; Shen H; Wang C; Sun Y; Howell SB; Lin X
Oncol Rep; 2014 Nov; 32(5):2150-8. PubMed ID: 25174950
[TBL] [Abstract][Full Text] [Related]
28. TGF-β promote epithelial-mesenchymal transition via NF-κB/NOX4/ROS signal pathway in lung cancer cells.
Ma M; Shi F; Zhai R; Wang H; Li K; Xu C; Yao W; Zhou F
Mol Biol Rep; 2021 Mar; 48(3):2365-2375. PubMed ID: 33792826
[TBL] [Abstract][Full Text] [Related]
29. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
[TBL] [Abstract][Full Text] [Related]
30. TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention.
Yang X; Chen GT; Wang YQ; Xian S; Zhang L; Zhu SM; Pan F; Cheng YX
Mol Med Rep; 2018 Feb; 17(2):2229-2238. PubMed ID: 29207048
[TBL] [Abstract][Full Text] [Related]
31. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
Ao Q; Su W; Guo S; Cai L; Huang L
Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
[TBL] [Abstract][Full Text] [Related]
32. NADPH Oxidase NOX4 Is a Critical Mediator of BRAF
Azouzi N; Cailloux J; Cazarin JM; Knauf JA; Cracchiolo J; Al Ghuzlan A; Hartl D; Polak M; Carré A; El Mzibri M; Filali-Maltouf A; Al Bouzidi A; Schlumberger M; Fagin JA; Ameziane-El-Hassani R; Dupuy C
Antioxid Redox Signal; 2017 May; 26(15):864-877. PubMed ID: 27401113
[TBL] [Abstract][Full Text] [Related]
33. IGF-1R and ErbB3/HER3 contribute to enhanced proliferation and carcinogenesis in trastuzumab-resistant ovarian cancer model.
Jia Y; Zhang Y; Qiao C; Liu G; Zhao Q; Zhou T; Chen G; Li Y; Feng J; Li Y; Zhang Q; Peng H
Biochem Biophys Res Commun; 2013 Jul; 436(4):740-5. PubMed ID: 23792093
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Notch‑Nox4‑reactive oxygen species signaling pathway induces cell death in high glucose‑treated human retinal endothelial cells.
Jiao W; Ji J; Li F; Guo J; Zheng Y; Li S; Xu W
Mol Med Rep; 2019 Jan; 19(1):667-677. PubMed ID: 30431086
[TBL] [Abstract][Full Text] [Related]
35. The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Zhang M; Jiang W; Xu C
Br J Cancer; 2014 Jul; 111(3):515-24. PubMed ID: 24921917
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.
Li J; Wang JJ; Yu Q; Chen K; Mahadev K; Zhang SX
Diabetes; 2010 Jun; 59(6):1528-38. PubMed ID: 20332345
[TBL] [Abstract][Full Text] [Related]
37. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
[TBL] [Abstract][Full Text] [Related]
38. ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.
Stieg DC; Wang Y; Liu LZ; Jiang BH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743145
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of Paeoniflorin against AOPP-induced oxidative injury in HUVECs by blocking the ROS-HIF-1α/VEGF pathway.
Song S; Xiao X; Guo D; Mo L; Bu C; Ye W; Den Q; Liu S; Yang X
Phytomedicine; 2017 Oct; 34():115-126. PubMed ID: 28899493
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
